According to the IMARC Group, the global artificial pancreas device systems market to exhibit a CAGR of around 18% during 2020-2025. An artificial pancreas device system (APDS) refers to an autonomous system for glycemic control. It consists of a continuous glucose monitoring system (CGM), an insulin infusion pump and a blood glucose device for calibrating CGM. The system aids in monitoring glucose levels in the body and adjusting the delivery of insulin for reducing high blood glucose levels, thereby regulating the function of the pancreas. Owing to these advantages, it is widely used in the treatment of type 1 diabetes around the world. Global Artificial Pancreas Device Systems Market Trends: The increasing…